Table 1 Clinical characteristics of progressing and non-progressing patients
Progressed | Non-progressed | |||
Gender | M (68%) | M (69%) | ||
BINET/RAI stage at diagnosis | A0 (72%) | A0 (92%) | ||
IGHV Status | UM (56%) | UM (8%) | ||
Median | Range | Median | Range | |
Age at diagnosis | 63 | 40–82 | 66 | 47–81 |
TTP (months) | 29 | 5–96 | – | – |
Follow-up without progression (months) | – | – | 77 | 41–101 |
Time to second sampling (months) | 29 | 5–96 | 39 | 30–77 |
Lymphocytes·109/L at diagnosis | 12.20 | 3.3-65.8 | 10.40 | 3.8-31.2 |
Lymphocytes·109/L at second sampling | 73.05 | 2.3-287.1 | 22.40 | 5.2-85.3 |